BlackRock Inc. - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 357 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$1,720,446,319
+12.2%
14,871,176
-0.2%
0.05%
+16.7%
Q2 2023$1,532,843,561
-6.0%
14,903,681
-0.2%
0.04%
-12.5%
Q1 2023$1,629,949,992
-3.2%
14,934,488
+0.9%
0.05%
-9.4%
Q4 2022$1,683,649,459
+74.2%
14,794,811
-5.3%
0.05%
+60.6%
Q3 2022$966,660,000
-17.0%
15,619,023
+7.0%
0.03%
-10.8%
Q2 2022$1,164,373,000
-20.0%
14,598,447
+5.5%
0.04%
-5.1%
Q1 2022$1,455,645,000
+3.8%
13,835,607
+6.4%
0.04%
+8.3%
Q4 2021$1,401,745,000
-5.3%
13,008,024
-3.8%
0.04%
-12.2%
Q3 2021$1,480,562,000
+13.0%
13,516,176
-3.4%
0.04%
+13.9%
Q2 2021$1,309,720,000
-7.5%
13,986,732
-9.0%
0.04%
-14.3%
Q1 2021$1,415,314,000
+36.2%
15,377,169
+8.2%
0.04%
+27.3%
Q4 2020$1,039,241,000
+15.8%
14,206,978
+23.0%
0.03%0.0%
Q3 2020$897,447,000
+42.7%
11,553,123
+2.1%
0.03%
+32.0%
Q2 2020$628,728,000
+106.9%
11,312,171
+10.2%
0.02%
+66.7%
Q1 2020$303,934,000
-18.9%
10,261,071
-0.9%
0.02%
+7.1%
Q4 2019$374,867,000
+30.8%
10,355,459
-1.6%
0.01%
+16.7%
Q3 2019$286,572,000
+4.7%
10,524,201
-7.5%
0.01%0.0%
Q2 2019$273,784,00011,379,2800.01%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q2 2020
NameSharesValueWeighting ↓
Kopp Family Office, LLC 544,835$57,322,00030.98%
Paulson & Co. 5,614,000$590,649,00018.18%
Avoro Capital Advisors LLC 6,500,000$683,865,00012.48%
1492 Capital Management LLC 121,840$12,819,0006.80%
Iron Triangle Partners LP 503,744$52,999,0006.30%
Tri Locum Partners LP 132,332$13,923,0005.44%
HealthCor Management, L.P. 710,110$74,711,0004.98%
Eversept Partners, LP 609,939$64,171,6824.93%
Bain Capital Public Equity Management II, LLC 1,286,371$135,339,0004.33%
PFM Health Sciences, LP 1,091,840$114,872,0004.30%
View complete list of HORIZON THERAPEUTICS PUB L shareholders